Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04464473 · ClinicalTrials.gov registry record · NA

cTBS/fMRI Study of Hierarchical Control in the PFC

A NA study, sponsored by Florida State University.

Completed
Registry status
NA
Development phase
53
Enrollment target

NCT04464473: Completed NA study, sponsored by Florida State University.

NCT04464473 is a NA study that has completed, run by Florida State University. The registered enrollment target is 53 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04464473, a NA study, has completed, sponsored by Florida State University.

COMPLETED
Registry status
NA
Development phase
53 participants
Enrollment target

Study Summary

The objective of this study is to examine the effect of transcranial magnetic stimulation (TMS) on the prefrontal cortex and posterior parietal cortex.

Primary Outcome

effective connectivity among areas of the prefrontal and posterior parietal cortex in the blood oxygenation level dependent (BOLD) signal assessed with functional magnetic resonance imaging (fMRI) \[note, this measure has no units, but effective connectivity is a rate measure, so is expressed in Hertz\]

Interventions

  • DEVICE transcranial magnetic stimulation

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2021-07-23
Est. Completion 2023-04-25
Phase NA
Florida State University

219 total trials

What the finished NCT04464473 record still lists

NCT04464473 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which transcranial magnetic stimulation is the first listed.

NCT04464473 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04464473 about?

NCT04464473 is a clinical study titled "cTBS/fMRI Study of Hierarchical Control in the PFC". The objective of this study is to examine the effect of transcranial magnetic stimulation (TMS) on the prefrontal cortex and posterior parietal cortex.

What is the current status of trial NCT04464473?

This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2021-07-23. Estimated completion is 2023-04-25.

What interventions are being tested in trial NCT04464473?

The interventions under investigation include: transcranial magnetic stimulation (DEVICE).

Who is sponsoring clinical trial NCT04464473?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04464473's enrollment target sits among peer trials

53 1271st of 2000 higher than 729 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04177004 · 53 participants · Phase 1

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

  • NCT04199741 · 53 participants · Phase 1

    PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

  • NCT04835129 · 53 participants · Phase 2

    Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

  • NCT04913805 · 53 participants · Phase 2

    Matching Perfusion and Metabolic Activity in HFpEF

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04464473, the US trial registry maintained by the National Library of Medicine. NCT04464473 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.